• The indicators included are priority areas of prescribing where there is variation within NHS Boards
  • Ensuring COPD medicines are reviewed and optimised may support the reduction of unwarranted variation
  • The indicators focus on ensuring quality prescribing and any recommendations made follow national clinical guidance
  • PIS Prescribing data cannot be separated by diagnosis however the Scottish Therapeutics Utility (STU) software enables GP practices to identify patients with Asthma or COPD. (See 'Scottish Therapeutics Utility (STU)')